Concepedia
Statistics
Publications
48
Citations
2.1K
H-Index
26
Active since
1978
Affiliations
Novo Nordisk (Denmark)(Current)
Eli Lilly (United States)
AstraZeneca (Sweden)
Uppsala University
AstraZeneca (United States)
Michael D.B. Swedberg is an author at Novo Nordisk (Denmark) specializing in medicine, pharmacology, and neuropharmacology.
Top concepts
MedicinePharmacologyNeuropharmacologyNeurosciencePharmacotherapyDrug DiscoverySocial SciencesPsychopharmacologyPsychiatryBehavioral Pharmacology
Publications per year
1978–2014
The γ-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats
Anders Fink‐Jensen, Peter D. Suzdak, Michael D.B. Swedberg et al. · European Journal of Pharmacology · 1992 · 183 citations
Awake Rats, Neurophysiology, γ-Aminobutyric Acid +10
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
Shannon He, Bymaster Fp, Calligaro Do et al. · PubMed · 1994 · 164 citations
Molecular Pharmacology, Medicinal Chemistry, Biochemistry +14
Xanomeline, an M1/M4 preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice
Harlan E. Shannon, Kurt Rasmussen, Frank P. Bymaster et al. · Schizophrenia Research · 2000 · 159 citations
Antipsychotic-like Activity, Psychiatry, Medicine +8
Effects of Infusion Rate of Intravenously Administered Morphine on Physiological, Psychomotor, and Self-Reported Measures in Humans
Lisa A. Marsch, Warren K. Bickel, Gary J. Badger et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 119 citations
Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease
Frank P. Bymaster, Celia A. Whitesitt, Harlan E. Shannon et al. · Drug Development Research · 1997 · 104 citations
Neurochemical Biomarkers, Pharmacotherapy, Experimental Pharmacology +19
1–5 of 48